Temperton, Nigel J. ORCID: 0000-0002-7978-3815 (2001) DNA vaccines against cytomegalovirus: current progress. International Journal of Antimicrobial Agents, 19 (3). pp. 169-172. ISSN 0924-8579 (doi:https://doi.org/10.1016/S0924-8579(01)00492-7)

Full text not available from this repository.

Abstract

The development of a vaccine for the prevention of primary cytomegalovirus (CMV) infection is a major public health priority. Live attenuated virus, recombinant viral vector, recombinant protein and peptide vaccines have been studied as potential vaccine candidates. In recent years, DNA vaccination strategies have been developed for many pathogens, including CMV. This review aims to bring together many aspects of this relatively new vaccine technology as applied to current research into the development of vaccines against CMV.

Item Type:	Article
Additional Information:	[1] This is a review article
Uncontrolled Keywords:	DNA vaccines, cytomegalovirus, antibody, CTL, protection
Subjects:	Q Science > QR Microbiology R Medicine > RC Internal medicine
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science > Medway School of Pharmacy
Related URLs:	Publisher Organisation
Last Modified:	16 Jul 2012 13:28
URI:	http://gala.gre.ac.uk/id/eprint/8568

Actions (login required)

View Item